Injectable Lipid Emulsions-Advancements, Opportunities and Challenges

被引:173
作者
Hippalgaonkar, Ketan [2 ]
Majumdar, Soumyajit [2 ,3 ]
Kansara, Viral [1 ]
机构
[1] Merck Sharp & Dohme Corp, RNAi Delivery & Proc Dev, Biol & Vaccines, West Point, PA 19486 USA
[2] Univ Mississippi, Dept Pharmaceut, Oxford, MS 38677 USA
[3] Univ Mississippi, Pharmaceut Sci Res Inst, Oxford, MS 38677 USA
来源
AAPS PHARMSCITECH | 2010年 / 11卷 / 04期
关键词
biodisposition; lipid emulsions; microfluidization; parenteral formulations; sterilization; MEDIUM-CHAIN TRIGLYCERIDES; TOTAL PARENTERAL-NUTRITION; OIL-IN-WATER; CHOLESTEROL-RICH MICROEMULSION; CRITICALLY-ILL PATIENTS; DRUG-CARRIER EMULSIONS; FAT EMULSIONS; LIPOPHILIC DRUGS; PHYSICOCHEMICAL PROPERTIES; SUBMICRON EMULSIONS;
D O I
10.1208/s12249-010-9526-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Injectable lipid emulsions, for decades, have been clinically used as an energy source for hospitalized patients by providing essential fatty acids and vitamins. Recent interest in utilizing lipid emulsions for delivering lipid soluble therapeutic agents, intravenously, has been continuously growing due to the biocompatible nature of the lipid-based delivery systems. Advancements in the area of novel lipids (olive oil and fish oil) have opened a new area for future clinical application of lipid-based injectable delivery systems that may provide a better safety profile over traditionally used long- and medium-chain triglycerides to critically ill patients. Formulation components and process parameters play critical role in the success of lipid injectable emulsions as drug delivery vehicles and hence need to be well integrated in the formulation development strategies. Physico-chemical properties of active therapeutic agents significantly impact pharmacokinetics and tissue disposition following intravenous administration of drug-containing lipid emulsion and hence need special attention while selecting such delivery vehicles. In summary, this review provides a broad overview of recent advancements in the field of novel lipids, opportunities for intravenous drug delivery, and challenges associated with injectable lipid emulsions.
引用
收藏
页码:1526 / 1540
页数:15
相关论文
共 159 条
[1]   Intravenous itraconazole emulsions produced by SolEmuls technology [J].
Akkar, A ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (01) :29-36
[2]   Formulation of intravenous Carbamazepine emulsions by SolEmuls® technology [J].
Akkar, A ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 55 (03) :305-312
[3]  
AMES MM, 1982, CANCER TREAT REP, V66, P1579
[4]  
[Anonymous], WATER INSOLUBLE DRUG
[5]   Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions [J].
Arimoto, I ;
Matsumoto, C ;
Tanaka, M ;
Okuhira, K ;
Saito, H ;
Handa, T .
LIPIDS, 1998, 33 (08) :773-779
[6]  
*ASTRAZENECA, DIPR INJ EM
[7]   Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma [J].
Azevedo, CHM ;
Carvalho, JP ;
Valduga, CJ ;
Maranhao, RC .
GYNECOLOGIC ONCOLOGY, 2005, 97 (01) :178-182
[8]   MEDIUM-CHAIN TRIGLYCERIDE-BASED FAT EMULSIONS - AN ALTERNATIVE ENERGY SUPPLY IN STRESS AND SEPSIS [J].
BACH, AC ;
STORCK, D ;
MERAIHI, Z .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1988, 12 (06) :S82-S88
[9]   MEDIUM-CHAIN TRIGLYCERIDES - AN UPDATE [J].
BACH, AC ;
BABAYAN, VK .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1982, 36 (05) :950-962
[10]   A prospective, randomized trial of intravenous fat: Emulsion administration in trauma victims requiring total parenteral nutrition [J].
Battistella, FD ;
Widergren, JT ;
Anderson, JT ;
Siepler, JK ;
Weber, JC ;
MacColl, K .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1997, 43 (01) :52-58